Curatia Medical

What Curatia Medical does

Curatia Medical Inc. is a privately held medical device company founded in 2015 and headquartered in Sunnyvale, California, with manufacturing operations in Suzhou, China. The company develops, manufactures, and sells interventional vascular access disposables used in cardiac, peripheral, neurovascular, and pulmonary procedures. Its portfolio of 13 product lines includes angiographic catheters (Ursa®), guiding catheters (Xcess®), hemostasis valve kits (AutoSeal™), RX and over-the-wire PTA balloon dilatation catheters (Vela™, Vela OTW, Navajo®, Bilia), introducer sheath sets (EXTesia, EXTesia Slim, Crosera), a distal access catheter (HW-Flex), and an aspiration catheter (Laredo Plus). Several products feature proprietary design elements such as kink-recovery sheath materials, hybrid braid constructions with 1:1 torque control, multi-layer Hi-way fusion catheter technology, and bi-level semi-compliant/non-compliant balloon platforms.

The company monetizes primarily through direct B2B sales of branded vascular access devices to hospitals and cardiac centers, with a global sales network covering 30-40+ countries across North America, Europe, South America, and Asia. It also operates an OEM manufacturing service that produces interventional disposables for other medical device companies under their own brands. Curatia markets via participation in major interventional cardiology conferences (EuroPCR, CMEF, Arab Health, Hospitalar, SOLACI, WHX) and through its corporate website, with distribution handled through direct enterprise field sales rather than third-party distributors.

Curatia's regulatory footprint is a defining structural feature: it holds FDA 510(k) clearance (e.g., EXTesia in April 2022), EU MDR certification (e.g., Xcess in January 2024), NMPA approval in China (e.g., Crosera in May 2024), Korea GMP, and ISO 13485:2016 certification, and has passed multiple unannounced FDA and TUV SUD audits with zero findings. The company is privately held with disclosed backing from Tianjin Haida Venture Capital Management and CDIB Capital Group, employs 51-100 staff across its two sites, and has not publicly disclosed revenue or ARR figures.

Name

Curatia Medical

Legal name

Curatia Medical Inc.

Website

https://curatiamed.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Short description

Curatia Medical is a Sunnyvale-headquartered, Suzhou-manufactured medical device company selling a 13-product portfolio of FDA- and CE-cleared interventional vascular access devices to hospitals and cardiac centers in 30-40+ countries, with parallel OEM manufacturing services.

Ownership category

akta.pro rank

Product category

Interventional Vascular Access Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK)

akta.pro secondary industry

Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)

Keywords

• Interventional vascular access
• Medical device manufacturing
• Cardiac catheters
• Introducer sheath sets
• OEM medical devices

Headquarters

HQ city

Suzhou

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Interventional Vascular Access Devices: Company generates revenue from selling proprietary vascular access devices including angiography catheters, guiding catheters, introducer sheaths, balloon catheters, distal access catheters, and aspiration catheters. Also provides OEM manufacturing services for customers.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Curatia Medical designs, manufactures, and sells interventional vascular access devices including angiographic catheters, guiding catheters, introducer sheaths, balloon dilatation catheters, distal access catheters, and aspiration catheters for cardiac, peripheral, neuro, and pulmonary procedures. The company also provides OEM manufacturing services for other medical device companies. Products are sold through a direct sales network covering 40+ countries across North America, Europe, South America, and Asia.

Product overview

Curatia Medical is a vascular access device company offering a diversified portfolio of interventional disposables covering cardiac, peripheral, neurovascular, and pulmonary applications. The portfolio includes angiography catheters (Ursa®), guiding catheters (Xcess®), balloon dilatation catheters (Vela™ RX and Vela OTW, Navajo® PTA), introducer sheaths (EXTesia, EXTesia Slim, Crosera Long Sheath Set), distal access catheters (HW-Flex), aspiration catheters (Laredo Plus), hemostasis valve kits (AutoSeal™), and peripheral RX balloon catheters (Bilia). In addition to its branded products sold in 40+ countries, the company provides OEM manufacturing services for customers.

Differentiator

Problem solved

Functional benefit

Brands

• Ursa®: Angiographic catheter for delivering radiopaque media to selected sites in the vascular system
• Xcess®
• AutoSeal™
• Vela™
• Navajo®
• EXTesia
• HW-Flex
• Bilia
• Crosera
• Laredo Plus
• EXTesia Slim
• Vela OTW
• OEM

Products and services

• Ursa® Angiographic Catheter

Quantifiable outcome

• Products sold to major US hospitals including Mount Sinai, Columbia University Clinical Center, and Houston Medical Center with positive clinical feedback
• +1 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• OEM CustomerscoreOEM/ Whitelabel/ Licensing PartnerCompany provides OEM manufacturing services for customers, manufacturing vascular access devices under other brand names. This represents a significant B2B revenue stream.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Teleflex: Teleflex is a broad incumbent in vascular access through its Arrow and specialty catheter franchises, with global hospital sales coverage that significantly exceeds Curatia's footprint. Direct product overlap in introducer sheaths and access catheters, but Teleflex operates a much wider medical device portfolio across multiple clinical specialties.
• Cordis (Cardinal Health): Cordis, now part of Cardinal Health, is a long-established interventional cardiology and vascular access portfolio covering sheaths, guiding catheters, and diagnostic catheters. Direct competition with Curatia's core vascular access products, particularly in US hospital accounts.
• Abbott Vascular: Abbott Vascular is a dominant global incumbent in interventional cardiology and peripheral vascular devices, including access sheaths, guiding catheters, and balloon catheters. Competes across Curatia's entire product portfolio with substantially greater R&D and commercial resources.
• Terumo Medical: Terumo is a global incumbent in interventional systems, including access sheaths, guidewires, and catheters used in cardiac and peripheral procedures. Significant product overlap with Curatia across multiple SKU categories, but Terumo operates at substantially larger scale with integrated procedure solutions.

Direct peers

• Penumbra: Penumbra specializes in aspiration thrombectomy catheters and distal access catheters, directly comparable to Curatia's Laredo Plus Aspiration Catheter and HW-Flex Distal Access Catheter. Both target peripheral vascular and neurovascular intervention procedures with similar device architectures.
• Asahi Intecc: Asahi Intecc is a Japanese manufacturer of guidewires, specialty catheters, and vascular access devices with global commercial reach. Highly comparable in product scope (guidewires, microcatheters, access devices) and in cross-border manufacturing model with strong Asia-Pacific presence.
• ACIST Medical Systems: ACIST Medical Systems (a Bracco subsidiary) develops interventional cardiology devices including contrast injection systems, diagnostic catheters, and vascular access products. Closely comparable product portfolio and end-user overlap with hospitals performing cardiac catheterization procedures.
• Merit Medical Systems: Merit Medical is a direct competitor in interventional vascular access devices, offering guiding catheters, introducer sheaths, and specialty catheters used in cardiac and peripheral procedures. Strong product overlap with Curatia's Ursa, Xcess, and EXTesia product families and similar enterprise hospital GTM motion.

Others

• Integer Holdings: Integer Holdings is a medical device contract manufacturer and OEM partner producing interventional catheters and access devices for major OEMs. Comparable to Curatia's OEM manufacturing service line, though Integer is significantly larger and serves a broader range of medical device categories.

Emerging players

• Surmodics: Surmodics is a smaller specialty medical device company focused on vascular intervention products including drug-coated balloons and specialty catheters. Comparable scale and emerging-product focus to Curatia, with overlapping peripheral vascular and access device portfolios.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks1 record

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/curatia-medical

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Curatia Medical